We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePrediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker.AuthorsSgroi DC; Carney E; Zarrella E; Steffel L; Binns SN; Finkelstein DM; Szymonifka J; Bhan AK; Shepherd LE; Zhang Y; Schnabel CA; Erlander MG; Ingle JN; Porter P; Muss HB; Pritchard KI; Tu D; Rimm DL; Goss PEPublicationJournal of the National Cancer Institute, 2013, Vol 105, Issue 14, p1036ISSN1460-2105Publication typearticleDOI10.1093/jnci/djt146